View Latest Medical and Pharma Bids and Tenders

Advanced Search

Rivaroxaban Tenders and Contracts

Rivaroxaban tenders contracts bids and business opportunities -

Summary:
Bidding For The Purchase Of Rivaroxaban 20 Mg Film-Coated Tablet By Electronic Bidding (E-Bidding)
Country:
Thailand
Estimated Cost:
THB 1131180
Notice Type:
Contract Award
Deadline:
Posting Date:
16 Aug 2024
 
 
 
Summary:
Bidding For The Purchase Of Rivaroxaban 15 Mg Film-Coated Tablet By Electronic Bidding (E-Bidding)
Country:
Thailand
Estimated Cost:
THB 625575
Notice Type:
Contract Award
Deadline:
Posting Date:
16 Aug 2024
 
 
 
Summary:
Np35924B Rivaroxaban Tablets
Country:
United Kingdom
Estimated Cost:
GBP 81156
Notice Type:
Contract Award
Deadline:
Posting Date:
02 Aug 2024
 
 
 
Summary:
* Electronic Bidding * - Price Registration For The Supply Of Legal Action Medicines: Cilostazole 100Mg, Desvenlafazine 100Mg, Desvenlafaxine, 50Mg, Ribociclib, Rivaroxaban 10Mg, Triexyphenidil, Rosuvastatin, Methotrexate 25Mg/Ml - Cilostazol, 1 00 Mg. Box With 60 Cebralat Tablets. Desvenlafaxine Succinate Monohydrate 100 Mg In Coated Extended-Release Tablet Imense. Desvenlafaxine Succinate Monohydrate 50 Mg In Elifore Controlled-Release Coated Tablet. Ribocycl *
Country:
Brazil
 
Notice Type:
Contract Award
Deadline:
Posting Date:
29 Jun 2024
 
 
 
Summary:
* Electronic Bidding * - Price Registration For The Supply Of Legal Action Medicines: Cilostazole 100Mg, Desvenlafazine 100Mg, Desvenlafaxine, 50Mg, Ribociclib, Rivaroxaban 10Mg, Triexyphenidil, Rosuvastatin, Methotrexate 25Mg/Ml - Cilostazol, 1 00 Mg. Box With 60 Cebralat Tablets. Desvenlafaxine Succinate Monohydrate 100 Mg In Coated Extended-Release Tablet Imense. Desvenlafaxine Succinate Monohydrate 50 Mg In Elifore Controlled-Release Coated Tablet. Ribocicl *
Country:
Brazil
 
Notice Type:
Contract Award
Deadline:
Posting Date:
27 Jun 2024
 
 
 
Summary:
Tender For Purchase Of Rivaroxaban 20 Mg Film-Coated Tablet By Electronic Bidding Method.
Country:
Thailand
Estimated Cost:
THB 2889000
Notice Type:
Procurement Plan
Deadline:
17 Jun 2025
Posting Date:
18 Jun 2024
 
 
 
Summary:
Medicines With The Active Ingredient Rivaroxaban (Atc: B01Af01 - With A Potency Of 2.5 Mg Per Divided Oral Dosage Form)
Country:
Germany
 
Notice Type:
Tender Notice
Deadline:
30 Apr 2026
Posting Date:
22 May 2024
 
 
 
Summary:
Medicines With The Active Ingredient Rivaroxaban (Atc: B01Af01 - In All Potencies Except 2.5 Mg Per Divided Oral Dosage Form)
Country:
Germany
 
Notice Type:
Tender Notice
Deadline:
30 Apr 2026
Posting Date:
22 May 2024
 
 
 
Summary:
Medicines With The Active Ingredient Rivaroxaban (Atc: B01Af01 - With A Potency Of 2.5 Mg Per Divided Oral Dosage Form)
Country:
Germany
 
Notice Type:
Tender Notice
Deadline:
30 Apr 2026
Posting Date:
22 May 2024
 
 
 
Summary:
Medicines With The Active Ingredient Rivaroxaban (Atc: B01Af01 - With A Potency Of 2.5 Mg Per Divided Oral Dosage Form)
Country:
Germany
 
Notice Type:
Tender Notice
Deadline:
30 Apr 2026
Posting Date:
22 May 2024